Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Stefanski

Showing results (51-60 of 106) with videos related to

Pageof 11
Sort By:
Inflammation|April 30, 1998
Induction of secretory phospholipase A2 confirms the systemic inflammatory nature of adjuvant arthritisM K Lin, A Katz, H van den Bosch, et al.
The Journal of Rheumatology|October 1, 1994
Phospholipase A2 in juvenile rheumatoid arthritis: correlation to disease type and activityW Pruzanski, K Albin-Cook, R M Laxer, et al.
Life Sciences|January 1, 1992
Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shockP Vadas, K Scott, G Smith, et al.
Journal of Lipid Research|November 4, 1998
Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDLW Pruzanski, E Stefanski, F C de Beer, et al.
Stem Cells (Dayton, Ohio)|August 1, 2015
In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One DestinationMichelle J Smith, Beau R Webber, Mahmood Mohtashami, et al.
Critical Care Medicine|January 1, 1988
Pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A2 levels with circulatory collapseP Vadas, W Pruzanski, E Stefanski, et al.
Blood Advances|October 25, 2019
Generation and function of progenitor T cells from StemRegenin-1-expanded CD34+ human hematopoietic progenitor cellsJastaranpreet Singh, Edward L Y Chen, Yan Xing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 26, 2012
FTY720 markedly increases alloengraftment but does not eliminate host anti-donor T cells that cause graft rejection on its withdrawalPatricia A Taylor, Ryan M Kelly, Nick D Bade, et al.
Journal of Clinical Apheresis|December 1, 2023
Validation of Nivestym compared to Neupogen: An NMDP analysisJoseph Maakaron, Katie Picotte, Kevin Tram, et al.
Inflammation|October 1, 1992
Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxinW Pruzanski, D W Wilmore, A Suffredini, et al.
Pageof 11

Showing results (51-60 of 106) with videos related to

Sort By:
Pageof 11
Inflammation|April 30, 1998
Induction of secretory phospholipase A2 confirms the systemic inflammatory nature of adjuvant arthritisM K Lin, A Katz, H van den Bosch, et al.
The Journal of Rheumatology|October 1, 1994
Phospholipase A2 in juvenile rheumatoid arthritis: correlation to disease type and activityW Pruzanski, K Albin-Cook, R M Laxer, et al.
Life Sciences|January 1, 1992
Serum phospholipase A2 enzyme activity and immunoreactivity in a prospective analysis of patients with septic shockP Vadas, K Scott, G Smith, et al.
Journal of Lipid Research|November 4, 1998
Lipoproteins are substrates for human secretory group IIA phospholipase A2: preferential hydrolysis of acute phase HDLW Pruzanski, E Stefanski, F C de Beer, et al.
Stem Cells (Dayton, Ohio)|August 1, 2015
In Vitro T-Cell Generation From Adult, Embryonic, and Induced Pluripotent Stem Cells: Many Roads to One DestinationMichelle J Smith, Beau R Webber, Mahmood Mohtashami, et al.
Critical Care Medicine|January 1, 1988
Pathogenesis of hypotension in septic shock: correlation of circulating phospholipase A2 levels with circulatory collapseP Vadas, W Pruzanski, E Stefanski, et al.
Blood Advances|October 25, 2019
Generation and function of progenitor T cells from StemRegenin-1-expanded CD34+ human hematopoietic progenitor cellsJastaranpreet Singh, Edward L Y Chen, Yan Xing, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 26, 2012
FTY720 markedly increases alloengraftment but does not eliminate host anti-donor T cells that cause graft rejection on its withdrawalPatricia A Taylor, Ryan M Kelly, Nick D Bade, et al.
Journal of Clinical Apheresis|December 1, 2023
Validation of Nivestym compared to Neupogen: An NMDP analysisJoseph Maakaron, Katie Picotte, Kevin Tram, et al.
Inflammation|October 1, 1992
Hyperphospholipasemia A2 in human volunteers challenged with intravenous endotoxinW Pruzanski, D W Wilmore, A Suffredini, et al.
Pageof 11